Your selections:
Therapeutic drug monitoring in anticancer agents: perspectives of Australian medical oncologists
- Flynn, Alexandra, Galettis, Peter, Gurney, Howard, Michael, Michael, Desar, Ingrid, Westerdijk, Kim, Schneider, Jennifer, Martin, Jennifer
- Chin, Paul K. L., Charles, Kellie, Day, Richard, Schneider, Jennifer, Doogue, Matthew, Han, Catherine H., Herd, Sarah, Harrison, Claire, O'Mara, Deborah, Murnion, Bridin, McGuire, Treasure M., Hilmer, Sarah N., Martin, Jennifer, Reith, David, Joyce, David, Lucas, Catherine, Holford, Nick
The valley of death: why Australia failed to develop clinically effective drugs in COVID-19
Complementary and alternative therapies in the palliative setting
- Martin, Jennifer H., Patel, Joanne
Expert advice for prescribing cannabis medicines for patients with epilepsy—drawn from the Australian clinical experience
- Lawson, John, O'Brien, Terry, Graham, Myfanwy, Renaud, Elianne, Jones, Dean, Freeman, Jeremy, Lawn, Nicholas, Martin, Jennifer H.
- Athavale, Akshay, Murnion, Bridin
Why maximum tolerated dose?
- Stampfer, Hans G., Gabb, Genevieve M., Dimmitt, Simon B.
Achieving the World Health Organization's vision for clinical pharmacology
- Martin, Jennifer H., Henry, David, Gray, Jean, Day, Richard, Bochner, Felix, Ferro, Albert, Pirmohamed, Munir, Mörike, Klaus, Schwab, Matthias
- Owens, Katie H., Medlicott, Natalie J., Zacharias, Matthew, Whyte, Ian M., Buckley, Nicholas A., Reith, David M.
An agenda for UK clinical pharmacology: An Australian perspective
Clinical pharmacology in research, teaching and health care
- Orme, Michael, Sjöqvist, Folke, Smith, Tony, Thuerman, Petra, Walubo, Andrew, Birkett, Donald, Brøsen, Kim, Cascorbi, Ingolf, Gustafsson, Lars L., Maxwell, Simon, Rago, Lembit, Rawlins, Michael, Reidenberg, Marcus
Are you sure you would like to clear your session, including search history and login status?